ArticleTurkish journal of medical sciences2026
Postoperative normocalcemic hyperparathyroidism: a comprehensive analysis of 510 cases.
Article in Turkish journal of medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background/aim: Postoperative normocalcemic hyperparathyroidism (NC-HPT) is defined as elevated parathyroid hormone (PTH) levels despite normal calcium levels after parathyroidectomy for primary hyperparathyroidism (PHPT). This study investigates the demographic, biochemical, and histopathological factors associated with NC-HPT in a large patient cohort and presents the follow-up outcomes. Materials and methods: The initial study sample included 571 patients who underwent surgery for PHPT between January 2018 and January 2024, 510 of whom were analyzed retrospectively after the application of the exclusion criteria. Preoperative and postoperative biochemical parameters, bone mineral density, pathological findings, and follow-up data were evaluated. NC-HPT was defined as postoperative PTH elevation in the presence of normocalcemia. Logistic regression and receiver operating characteristic curve analyses were performed. Results: NC-HPT developed in 104 (20.4%) of the 510 patients analyzed in the study. The condition peaked in the third postoperative month and then gradually declined, with 86.5% of cases resolving by month 30. Univariate analysis revealed elevated preoperative PTH, high alkaline phosphatase (ALP), and parathyroid hyperplasia to be significant predictors. In multivariate analysis, only preoperative PTH level (OR: 1.003; 95% CI: 1.002-1.005; p < 0.001) and hyperplasia (OR: 3.311; 95% CI: 1.277-8.547) remained independent risk factors. ROC analysis identified a preoperative PTH cutoff value of 298 pg/mL with an AUC of 0.665 (95% CI: 0.608-0.723). No significant associations were observed with other demographic, biochemical, or radiological parameters. Conclusion: NC-HPT occurs in approximately 20% of patients undergoing surgery for PHPT but often resolves during follow-up. Elevated preoperative PTH levels and parathyroid hyperplasia are independent predictors of NC-HPT, and patients with these characteristics should be monitored more closely in the postoperative period.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.